THE US HAS A DRUG-RESISTANT FUNGUS PROBLEM

Candida auris, a drug-resistant fungus discovered in 2016, is increasingly reported in multiple states, especially Georgia and Florida. The CDC calls it an “urgent antimicrobial resistance threat.” It mainly spreads in healthcare settings among immunocompromised patients via medical devices. Symptoms are mild, but it has a high fatality rate. Its resilience complicates control measures in hospitals.

Residual cancer linked to worse long-term outcomes: Scientists

Researchers warn that residual microscopic cancer may persist post-radiotherapy, despite scans indicating tumor absence. This issue, highlighted by Dr. Muzamil Arshad and colleagues in Oncotarget, suggests treatment success reviews need rethinking. Residual disease is linked to higher recurrence and reduced survival across various cancers, stressing the importance of thorough follow-up assessments.